Episode 40 - On The Wards: The Antibodies of Wrath | IVIG and Rituximab Reactions
Bloody Minded
00:00
Risks and Management of Rituximab Treatment
This chapter explores the use of chimeric hybrid antibodies, particularly rituximab, in patient treatment and highlights its well-tolerated nature alongside potential infusion-related risks. It details pre-medication strategies, grading of reactions, and monitoring protocols to ensure patient safety during treatment. The chapter also addresses the immune implications and complications associated with rituximab, including infection susceptibility and the rare occurrence of progressive multifocal leukencephalopathy.
Transcript
Play full episode
